Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when RKLB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRocket Lab launches up to $1.94B ATM program to fund Iridium acquisition, announces HSR clearance
Filed August 13, 2026 · Period ending August 13, 2026 · ~1 min read
Key Changes
-
high
Rocket Lab established a $1.94B at-the-market equity program to fund cash payments for the Iridium acquisition and reduce bridge debt commitments. The program replaces a prior May 2026 ATM, carrying forward the unsold amount.
Item 8.01 — Other Events verify on EDGAR → -
high
HSR antitrust waiting period for the Iridium acquisition expired August 12, 2026. Rocket Lab filed Form S-4 to register shares for Iridium shareholders and submitted FCC applications for license transfers.
Item 7.01 — Regulation FD Disclosure verify on EDGAR → -
high
Rocket Lab intends to amend Iridium's existing $1.775B term loan to keep it in place post-acquisition, reducing reliance on the $3.6B bridge facility at more favorable rates. Lender consent required.
Item 7.01 — Regulation FD Disclosure verify on EDGAR → -
medium
The ATM program includes Initially Priced Forward Transactions (deferred cash settlement at company's election) and Collared Forward Transactions (floor and cap pricing based on hedging period VWAP).
Item 8.01 — Other Events verify on EDGAR →
Summary
Rocket Lab disclosed a $1.94 billion at-the-market equity program to finance its pending acquisition of Iridium Communications. The program replaces a prior May 2026 ATM and carries forward the unsold offering amount—this is not an increase in total capacity. Proceeds will fund cash payments to Iridium shareholders and reduce commitments under Rocket Lab's $3.6 billion bridge facility.
The company also plans to amend Iridium's existing $1.775 billion term loan to keep it in place post-close, which would further reduce bridge reliance at better rates, though lender consent is required and not assured.
The filing updates Iridium acquisition progress: the HSR antitrust waiting period expired August 12, Rocket Lab filed its Form S-4 to register shares for the equity consideration, and the companies submitted FCC applications for license transfers. These are standard regulatory steps toward closing. The ATM structure includes traditional sales and two forward transaction types—Initially Priced (deferred settlement at Rocket Lab's election) and Collared (floor/cap pricing)—giving the company flexibility in timing capital raises and managing dilution. Retail holders should watch for ATM execution disclosures and FCC approval timing, as both will shape the acquisition's financing mix and dilution profile.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
Rocket Lab announces equity distribution agreement and provides update on Iridium acquisition progress.
Added in current filing · verify on EDGAR →
On August 13, 2026, Rocket Lab Corporation (the “Company”) issued a press release announcing the entry into the Equity Distribution Agreement (as defined below).
Rocket Lab entered into an Equity Distribution Agreement, a type of at-the-market offering program that allows the company to sell shares incrementally over time. The specific terms, size, and intended use of proceeds are disclosed in the referenced press release (Exhibit 99.1), which is not included in this 8-K body.
Added in current filing · verify on EDGAR →
on August 13, 2026, the Company issued a press release announcing progress on its previously announced proposed acquisition of Iridium Communications Inc.
Rocket Lab provided an update on its previously announced proposed acquisition of Iridium Communications Inc. The specific nature of the progress is detailed in the referenced press release (Exhibit 99.2), which is not included in this 8-K body. This is a material transaction update for a significant acquisition.
Event · Item 8.01 — Other Events
Rocket Lab entered into an equity distribution agreement to sell up to $1.94 billion of common stock through at-the-market and forward sale transactions.
Added in current filing · verify on EDGAR →
On August 13, 2026, the Company entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Deutsche Bank Securities Inc. and Wells Fargo Securities, LLC, as sales agents (in such capacity, each, a “Sales Agent” and, collectively, the “Sales Agents”), the Forward Sellers (as defined below) and the Forward Purchasers (as defined below). Under the Equity Distribution Agreement, the Company may offer and sell, from time to time, shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”) (the “Shares”), through or to the Sales Agents, acting as the Company’s agents or principals, having an aggregate offering price of up to $1,944,369,826 or by the Forward Sellers, acting as sales agents for the relevant Forward Purchasers.
Rocket Lab established an at-the-market equity offering program allowing it to sell up to approximately $1.94 billion of common stock over time through Deutsche Bank and Wells Fargo as sales agents. The program includes both traditional ATM sales and forward sale agreements, giving the company flexibility in timing and structure of capital raises. Sales agents will receive commissions up to 2.00% of sales prices.
Added in current filing · verify on EDGAR →
In a Forward Transaction under one form of forward sale agreement, referred to as an “Initially Priced Forward Transaction,” the Company may enter into one or more Initially Priced Forward Transactions with a Forward Purchaser, pursuant to which the Company will receive the forward sale price under the forward sale agreement at the settlement of the Initially Priced Forward Transaction, subject to the price adjustment and other provisions of the applicable forward sale agreement. The initial forward sale price per share under each Initially Priced Forward Transaction will be equal to the product of (1) an amount equal to one minus the applicable forward hedge selling commission rate and (2) the adjusted volume weighted average hedge price per share at which the borrowed shares of Common Stock were sold pursuant to the Equity Distribution Agreement by the relevant Forward Seller to hedge the relevant Forward Purchaser’s exposure under such Initially Priced Forward Transaction. The Company will not initially receive any proceeds from the sale of borrowed shares by the relevant Forward Seller. The Company expects to receive proceeds from the sale of shares of Common Stock upon future physical settlement of the relevant Initially Priced Forward Transaction with the relevant Forward Purchaser on dates specified by the Company on or prior to the maturity date of such Initially Priced Forward Transaction.
The Initially Priced Forward Transaction structure allows Rocket Lab to defer receiving cash proceeds until a future settlement date it chooses, while the forward purchaser's agent sells borrowed shares immediately to hedge. The forward sale price is based on the volume-weighted average price of those borrowed shares sold, minus commissions. This gives Rocket Lab flexibility to time when it receives capital and issues shares, potentially allowing it to benefit from future stock price appreciation.
Added in current filing · verify on EDGAR →
In a separate Forward Transaction under another form of forward sale agreement, referred to herein as a “Collared Forward Transaction,” the Company may enter into one or more collared forward transactions (“Collared Forward Sale Agreements”) with Deutsche Bank AG, London Branch or Wells Fargo Bank, National Association, each acting in its capacity as a Forward Purchaser (the “Collared Forward Purchaser”), pursuant to which the Company will agree to sell to the relevant Collared Forward Purchaser up to the number of shares of Common Stock specified in the Collared Forward Sale Agreement (subject to adjustment as set forth therein) and the relevant Collared Forward Purchaser will borrow from third-party stock lenders and sell the maximum number of shares of Common Stock deliverable pursuant to the Collared Forward Transaction (the “Hedging Shares”) through the related Sales Agent, acting as a Forward Seller (the “Collared Forward Seller”) over a period of time to be agreed between the Company and the relevant Collared Forward Purchaser (an “Initial Hedging Period”), all subject to the terms of the Equity Distribution Agreement and the Collared Forward Sale Agreement.
The Collared Forward Transaction structure establishes a floor and cap price based on the weighted average price at which borrowed shares are sold during an initial hedging period. Rocket Lab receives a minimum price per share (the floor) but caps its upside (the cap), providing price certainty within a range. The company can receive prepayments based on the floor price and additional proceeds at settlement if the stock price exceeds the floor, up to the cap level.
Show 2 minor / wording changes
Added in current filing · verify on EDGAR →
The Company has been advised by each Collared Forward Purchaser that it expects that, on the same days during the Initial Hedging Period when the Collared Forward Seller is selling a number of Hedging Shares underlying the Collared Forward Transaction, the relevant Collared Forward Purchaser or its affiliates or agents will be contemporaneously purchasing a substantial portion of such number of shares in the open market for its own account, as each Collared Forward Purchaser expects its initial hedge position in respect of the Collared Forward Transaction to be less than the maximum number of shares underlying the Collared Forward Transaction.
During Collared Forward Transactions, the forward purchasers expect to simultaneously buy a substantial portion of shares in the open market while their agents sell borrowed shares, as their initial hedge position will be less than the maximum transaction size. This contemporaneous buying and selling activity could create offsetting market pressure during the initial hedging period.
Added in current filing · verify on EDGAR →
Only one Sales Agent or Forward Seller will be permitted to conduct sales of shares of Common Stock at any given time pursuant to the Equity Distribution Agreement, and no sales of shares of Common Stock by any Sales Agents acting on the Company’s behalf, or by the relevant Forward Seller on behalf of the relevant Forward Purchaser in connection with any Initially Priced Forward Transaction, will occur simultaneously with any sales of the Hedging Shares by a Collared Forward Seller on behalf of a Collared Forward Purchaser or contemporaneous purchases of shares by such Collared Forward Purchaser in connection with the establishment of its initial delta hedge with respect to any Collared Forward Transaction.
The agreement restricts multiple agents from selling shares simultaneously and prevents overlap between different transaction types. This coordination mechanism is designed to avoid excessive market impact from multiple concurrent selling programs, though it may limit the speed at which Rocket Lab can execute large capital raises.
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
Rocket Lab currently intends to use all or a portion of the net proceeds from the sale of Shares under the ATM Program to fund cash payments under its previously announced proposed acquisition of Iridium Communications Inc. (the “Iridium Acquisition”) and reduce the commitments under its committed senior secured debt bridge facility.
The company intends to use ATM proceeds to fund cash payments for the previously announced Iridium Communications acquisition and to reduce commitments under its senior secured debt bridge facility. The offering is not conditioned on completing the Iridium acquisition, and excess proceeds would be used for future growth, potential acquisitions, and general corporate purposes.
Added in current filing · view on EDGAR →
The Company also separately announced today additional updates on the Iridium Acquisition, including the expiration of the HSR waiting period, the initial filing of its Registration Statement on Form S-4 related to the transaction (which registration statement has not yet become effective), the filing of its FCC applications, and updates on its capital strategy for the Iridium Acquisition.
Rocket Lab disclosed regulatory progress on the Iridium acquisition: the HSR antitrust waiting period has expired, the company filed its initial S-4 registration statement (not yet effective), and submitted FCC applications. These are standard steps toward closing a major acquisition, indicating the transaction is advancing through required regulatory approvals.
Event · Exhibit 99.2
Added in current filing · view on EDGAR →
Rocket Lab announced today that the waiting period under the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with its pending acquisition of Iridium expired at 11:59 p.m., Eastern Time, on August 12, 2026.
The HSR waiting period for Rocket Lab's acquisition of Iridium Communications has expired, clearing a key U.S. antitrust hurdle. This is a standard regulatory milestone for large M&A transactions and removes one condition to closing.
Added in current filing · view on EDGAR →
Rocket Lab also today filed its Registration Statement on Form S-4 with the U.S. Securities and Exchange Commission (the “SEC”) related to the Iridium acquisition to register the Rocket Lab securities to be delivered to Iridium shareholders to satisfy the equity consideration at the closing of the transaction.
Rocket Lab filed a Form S-4 to register the shares it will issue to Iridium shareholders as part of the acquisition consideration. This filing is required before the equity portion of the deal can close and represents progress toward completing the transaction.
Added in current filing · view on EDGAR →
Rocket Lab further announced that on August 10, 2026, Rocket Lab and Iridium filed with the Federal Communications Commission (“FCC”) applications seeking its consent to transfer control of Iridium’s licenses and authorizations to Rocket Lab.
Rocket Lab and Iridium filed applications with the FCC to transfer control of Iridium's spectrum licenses and authorizations. FCC approval is a critical regulatory condition for the acquisition, as Iridium operates a satellite communications network requiring FCC licenses.
Added in current filing · view on EDGAR →
The Company also separately announced today a new at the market program that replaces the Company’s May 2026 program and carries forward the unsold offering amount under that prior program. Amounts raised under the new program are intended to reduce the remaining commitments under the bridge loan through equity transactions.
Rocket Lab launched a new at-the-market equity offering program to raise capital and reduce its bridge loan commitments for the Iridium acquisition. The program replaces a prior May 2026 ATM and will dilute existing shareholders as shares are sold, though the amount and timing are not specified.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 14, 2026 · How we verify